newsfilter
← Latest News
GlobeNewswire·

Evoke Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update

Entered into an Agreement to be acquired by QOL Medical Net product sales for the third quarter of 2025 reached $4.3 million; up 61% year-over-year Gimoti patent life for Gimoti extended through November 2038